跳至主要内容
临床试验/PACTR202402484795209
PACTR202402484795209招募中Unknown

To compare the effects of daily and weekly oral iron supplementations on hematological markers, GI side effects, and adherence statuses during pregnancy in healthy non-anemic pregnant women: a randomized control trial

Arba Minch University0 个研究点目标入组 170 人开始时间: 2023年8月4日最近更新:

试验速览

阶段
Unknown
状态
招募中
入组人数
170

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
13 Year(s) 至 18 Year(s)(—)
性别
Female

入选标准

  • women before 25 weeks of gestation
  • - hemoglobin level at least 11 g/dl
  • - healthy and non-anemic
  • - never received iron-folic acid in the current pregnancy

排除标准

  • - women who disagree with consent
  • - women who will not attend full antenatal care at the study health facility

研究者

相似试验

尚未招募
4 期
The efficacy of intermittent versus daily oral iron supplementation in anaemic pregnant women.Anaemia1000208610010273
NL-OMON51243Martini Ziekenhuis58
进行中(未招募)
1 期
The efficacy and safety of a daily oral administration of S06911 (strontium ranelate 2g/vitamin D3 1000 IU fixed combination) on vitamin D insufficiency in the treatment of osteoporotic postmenopausal women and men. A prospective, international phase III study with a 6-month double-blind period to assess the efficacy and safety of a daily oral administration of S06911 versus S12911 (strontium ranelate 2g) and a 6-month open-labelled extension for a subgroup of patients to assess safety of a daily oral administration of S06911.Osteoporotic men and osteoporotic postmenauposal womenMedDRA version: 12.0Level: LLTClassification code 10031283Term: Osteoporosis fractureMedDRA version: 12.0Level: LLTClassification code 10031285Term: Osteoporosis postmenopausal
EUCTR2009-013935-39-FRInstitut de Recherches Internationales Servier500
进行中(未招募)
不适用
Efficacy and safety of strontium ranelate/vitamin D3 combination on vitamin D insufficiency in the treatment of osteoporotic patient.Osteoporotic men and postmenauposal womenMedDRA version: 13.1Level: PTClassification code 10031285Term: Osteoporosis postmenopausalSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 13.1Level: LLTClassification code 10031283Term: Osteoporosis fractureSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
EUCTR2009-013935-39-BEInstitut de Recherches Internationales Servier500
进行中(未招募)
1 期
The efficacy and safety of a daily oral administration of S06911 (strontium ranelate 2g/vitamin D3 1000 IU fixed combination) on vitamin D insufficiency in the treatment of osteoporotic postmenopausal women and men. A prospective, international phase III study with a 6-month double-blind period to assess the efficacy and safety of a daily oral administration of S06911 versus S12911 (strontium ranelate 2g) and a 6-month open-labelled extension for a subgroup of patients to assess safety of a daily oral administration of S06911.Osteoporotic men and postmenauposal womenMedDRA version: 12.0 Level: LLT Classification code 10031283 Term: Osteoporosis fractureMedDRA version: 12.0 Level: LLT Classification code 10031285 Term: Osteoporosis postmenopausal
EUCTR2009-013935-39-GBInstitut de Recherches Internationales Servier500
进行中(未招募)
不适用
The efficacy and safety of a daily oral administration of S06911 (strontium ranelate 2g/vitamin D3 1000 IU fixed combination) on vitamin D insufficiency in the treatment of osteoporotic postmenopausal women and men. A prospective, international phase III study with a 6-month double-blind period to assess the efficacy and safety of a daily oral administration of S06911 versus S12911 (strontium ranelate 2g) and a 6-month open-labelled extension for a subgroup of patients to assess safety of a daily oral administration of S06911.
EUCTR2009-013935-39-HUInstitut de Recherches Internationales Servier500